Tools

LEADER 06397cam a2200613 a 4500

001 on1338839272;

003 OCoLC;

005 20230725093158.0;

006 m o d ;

007 cr un|---aucuu;

008 220806s2022 sz o 000 0 eng d;

019 a| 1338831192;

020 a| 9783031118029q| (electronic bk.);

020 a| 3031118022q| (electronic bk.);

020 z| 9783031118012q| (print);

020 z| 3031118014;

024 7 a| 10.1007/978-3-031-11802-92| doi;

035 a| (Sirsi) o1338839272;

035 a| (OCoLC)1338839272z| (OCoLC)1338831192;

049 a| NEHH;

050 4 a| RJ506.H9;

082 04 a| 616.85/892| 23/eng/20220815;

245 00 a| New discoveries in the behavioral neuroscience of attention-deficit hyperactivity disorder /c| S Clare Stanford, Emma Sciberras, editors.;

260 a| Cham :b| Springer,c| 2022.;

300 a| 1 online resource (503 pages).;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| Current Topics in Behavioral Neurosciences ;v| v. 57;

505 0 a| Intro -- Preface -- Contents -- ADHD in Children and Adults: Diagnosis and Prognosis -- 1 Introduction -- 2 Diagnosis -- 3 ADHD in Preschool Children -- 4 ADHD in School-Aged Children -- 5 ADHD in Adolescents -- 6 ADHD in Adults -- 7 Conclusion -- References -- Current Pharmacological Treatments for ADHD -- 1 Introduction -- 2 Medications for ADHD and Their Mechanism of Action -- 2.1 Stimulant Medications -- 2.1.1 Methylphenidate -- 2.1.2 Amphetamine -- 2.2 Nonstimulants -- 2.2.1 Atomoxetine -- 2.2.2 Guanfacine and Clonidine -- 3 Pharmacokinetics of ADHD Medications;

505 8 a| 4 ADHD Medications and the Cognitive Neuroscience of ADHD -- 5 Efficacy and Tolerability: Comparison Between Medications -- 6 Effects of ADHD Medications on Other Outcomes and Comorbidities -- 7 Factors to Consider When Choosing Treatments -- 8 Conclusions -- References -- The Benefits and Limitations of Stimulants in Treating ADHD -- 1 Introduction -- 2 Stimulants Used to Treat ADHD -- 3 Political, Ethical, and Moral Issues Relating to the Use of Stimulants for the Treatment of ADHD -- 4 The Treatment of Subsyndromal ADHD and the Use of Stimulants as Cognitive Enhancers;

505 8 a| 5 Comparative Efficacy Between Stimulants and Non-pharmacological Treatments for ADHD -- 6 Comparative Efficacy, Effectiveness, and Safety of Pharmacological Treatments for ADHD -- 6.1 Children and Adolescents -- 6.2 Adults -- 6.3 Comparisons Between Different Stimulant Formulations -- 7 Clinical Implications of These Findings -- 8 Monitoring Treatment Response and the Potential Benefits of Integrating Measurement-Based Care Approaches into Clinical Prac ... -- 9 Do Stimulants Work and Are They Safe Over the Long Term? -- 10 Considerations for Different Clinical Populations;

505 8 a| 11 Summary and Conclusions -- References -- New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development -- 1 Introduction -- 2 Current Status of Drugs to Treat ADHD -- 3 Non-clinical and Clinical Pharmacology of Approved Drugs to Treat ADHD -- 3.1 Lisdexamfetamine -- 3.2 Viloxazine -- 3.3 Prodrugs for Methylphenidate -- 3.4 Comment (Summary/Overview) -- 4 Update on the Progress of R & D in the Search for New Drugs to Treat ADHD -- 4.1 Centanafadine -- 4.2 Mazindol -- 4.3 Dasotraline -- 4.4 Vortioxetine -- 4.5 Droxidopa -- 4.6 Baicalin -- 4.7 Summary;

505 8 a| 5 Progress in the Pharmacological Management of ADHD -- 5.1 Efficacy in ADHD -- 5.2 Once-Daily Medication -- 5.3 Relapse on Withdrawal -- 5.4 Drug-Induced Side Effects -- 5.5 Abuse Liability -- 6 The Link Between ADHD and Binge-Eating Disorder -- 7 Concluding Remarks -- References -- Effects of Methylphenidate on the Dopamine Transporter and Beyond -- 1 Introduction -- 2 Methylphenidate and the Central Catecholamine Systems -- 2.1 Methylphenidate and the Catecholamine Transporters -- 2.2 Methylphenidate and Other Catecholamine Protein Targets;

500 a| 2.3 Summary: Methylphenidate and the Catecholamine Systems;

520 a| New Discoveries in the Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder reviews the latest developments in preclinical and clinical research of Attention Deficit Hyperactivity Disorder. As well as updating key chapters that were included in an earlier edition, this volume includes some new topics that are attracting a great deal of interest and point the way to new and promising directions for future research. The chapters follow five main themes: Current perspectives on the clinical profile of ADHD and its treatment, common co-occurring conditions, neurobiological studies examining brain function and genetics, animal and in vitro studies, and future directions. This combination of topics emphasises the translational relevance and validity of preclinical research so as to enable a better understanding of ADHD and to highlight the promising strategies for developing new treatments.;

588 0 a| Online resource; title from PDF title page (SpringerLink, viewed August 15, 2022).;

650 0 a| Attention-deficit hyperactivity disorder.=| ^A119585;

650 0 a| Attention-deficit hyperactivity disorder in adults=| ^A384447;

650 0 a| Clinical neuropsychology.=| ^A234066;

650 0 a| Neuropsychiatry.=| ^A1537;

700 1 a| Stanford, S. Clare.=| ^A1457299;

700 1 a| Sciberras, Emma.=| ^A1456628;

830 0 a| Current topics in behavioral neurosciences ;v| v. 57.=| ^A1011313;

856 40 z| Direct link to eBooku| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=7069293;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL102p| $155.820| HSLo| HMT;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER96o| HMT;

994 a| C0b| NEH;

596 a| 1 4;

998 a| 6157772;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6157772-1001l| HSLELECm| HSLp| $155.82r| Ys| Yt| HGENEBKu| 6/21/2023x| EBOOKz| HERESOURCE0| HSLo| .STAFF. HMT;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6157772-2001l| JNETm| JOYNERr| Ys| Yt| JNE3BKu| 6/21/2023x| EBOOKz| JERESOURCEo| .STAFF. HMT;

New discoveries in the behavioral neuroscience of attention-deficit hyperactivity disorder / S Clare Stanford, Emma Sciberras, editors.

Other author	Stanford, S. Clare.
Other author	Sciberras, Emma.
Format	Electronic
Publication Info	Cham : Springer, 2022.
Description	1 online resource (503 pages).
Supplemental Content	Direct link to eBook
Subjects	Attention-deficit hyperactivity disorder. Attention-deficit hyperactivity disorder in adults Clinical neuropsychology. Neuropsychiatry.

Series	Current Topics in Behavioral Neurosciences ; v. 57 Current topics in behavioral neurosciences ; v. 57. ^A1011313
Contents	Intro -- Preface -- Contents -- ADHD in Children and Adults: Diagnosis and Prognosis -- 1 Introduction -- 2 Diagnosis -- 3 ADHD in Preschool Children -- 4 ADHD in School-Aged Children -- 5 ADHD in Adolescents -- 6 ADHD in Adults -- 7 Conclusion -- References -- Current Pharmacological Treatments for ADHD -- 1 Introduction -- 2 Medications for ADHD and Their Mechanism of Action -- 2.1 Stimulant Medications -- 2.1.1 Methylphenidate -- 2.1.2 Amphetamine -- 2.2 Nonstimulants -- 2.2.1 Atomoxetine -- 2.2.2 Guanfacine and Clonidine -- 3 Pharmacokinetics of ADHD Medications
Contents	4 ADHD Medications and the Cognitive Neuroscience of ADHD -- 5 Efficacy and Tolerability: Comparison Between Medications -- 6 Effects of ADHD Medications on Other Outcomes and Comorbidities -- 7 Factors to Consider When Choosing Treatments -- 8 Conclusions -- References -- The Benefits and Limitations of Stimulants in Treating ADHD -- 1 Introduction -- 2 Stimulants Used to Treat ADHD -- 3 Political, Ethical, and Moral Issues Relating to the Use of Stimulants for the Treatment of ADHD -- 4 The Treatment of Subsyndromal ADHD and the Use of Stimulants as Cognitive Enhancers
Contents	5 Comparative Efficacy Between Stimulants and Non-pharmacological Treatments for ADHD -- 6 Comparative Efficacy, Effectiveness, and Safety of Pharmacological Treatments for ADHD -- 6.1 Children and Adolescents -- 6.2 Adults -- 6.3 Comparisons Between Different Stimulant Formulations -- 7 Clinical Implications of These Findings -- 8 Monitoring Treatment Response and the Potential Benefits of Integrating Measurement-Based Care Approaches into Clinical Prac ... -- 9 Do Stimulants Work and Are They Safe Over the Long Term? -- 10 Considerations for Different Clinical Populations
Contents	11 Summary and Conclusions -- References -- New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development -- 1 Introduction -- 2 Current Status of Drugs to Treat ADHD -- 3 Non-clinical and Clinical Pharmacology of Approved Drugs to Treat ADHD -- 3.1 Lisdexamfetamine -- 3.2 Viloxazine -- 3.3 Prodrugs for Methylphenidate -- 3.4 Comment (Summary/Overview) -- 4 Update on the Progress of R & D in the Search for New Drugs to Treat ADHD -- 4.1 Centanafadine -- 4.2 Mazindol -- 4.3 Dasotraline -- 4.4 Vortioxetine -- 4.5 Droxidopa -- 4.6 Baicalin -- 4.7 Summary
Contents	5 Progress in the Pharmacological Management of ADHD -- 5.1 Efficacy in ADHD -- 5.2 Once-Daily Medication -- 5.3 Relapse on Withdrawal -- 5.4 Drug-Induced Side Effects -- 5.5 Abuse Liability -- 6 The Link Between ADHD and Binge-Eating Disorder -- 7 Concluding Remarks -- References -- Effects of Methylphenidate on the Dopamine Transporter and Beyond -- 1 Introduction -- 2 Methylphenidate and the Central Catecholamine Systems -- 2.1 Methylphenidate and the Catecholamine Transporters -- 2.2 Methylphenidate and Other Catecholamine Protein Targets
Abstract	New Discoveries in the Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder reviews the latest developments in preclinical and clinical research of Attention Deficit Hyperactivity Disorder. As well as updating key chapters that were included in an earlier edition, this volume includes some new topics that are attracting a great deal of interest and point the way to new and promising directions for future research. The chapters follow five main themes: Current perspectives on the clinical profile of ADHD and its treatment, common co-occurring conditions, neurobiological studies examining brain function and genetics, animal and in vitro studies, and future directions. This combination of topics emphasises the translational relevance and validity of preclinical research so as to enable a better understanding of ADHD and to highlight the promising strategies for developing new treatments.
General note	2.3 Summary: Methylphenidate and the Catecholamine Systems
Source of description	Online resource; title from PDF title page (SpringerLink, viewed August 15, 2022).
Issued in other form	Print version: Stanford, S. Clare. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder. Cham : Springer International Publishing AG, ©2022 9783031118012
ISBN	9783031118029 (electronic bk.)
ISBN	3031118022 (electronic bk.)
ISBN	(print)
Standard identifier#	10.1007/978-3-031-11802-9

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

New discoveries in the behavioral neuroscience of attention-deficit hyperactivity disorder / S Clare Stanford, Emma Sciberras, editors.

Click here for more information about this title

Availability